AstraZeneca , a London pharmaceutical company that has its U.S. headquarters in Wilmington, said Thursday it plans to cut about 400 positions in the United States next year.
The pharmaceutical company said the reductions will include 70 vacant positions that will not be filled and 330 who have jobs.
“This will be very difficult for our entire organization, particularly the people who are directly impacted,” said Rich Fante, president of AstraZeneca U.S., in a statement. “However, these changes are necessary to build a leaner, more efficient organization that will enable the company to continue delivering against our mission of patient health and sustaining a strong business for years to come.”
AstraZeneca (NYSE:AZN) plans to began notify the workers who will be laid off, effective early next year, in December. The job cuts are not expected to affect sales staff.
Thursday, October 06, 2011
AstraZeneca cutting 400 U.S. jobs - Philadelphia Business Journal